In a previous report the effectiveness of intraperitoneal bupivacaine in re
ducing pain following laparoscopic cholecystectomy was demonstrated. Other
methods of pain relief are commonly used but none has been compared followi
ng laparoscopic cholecystectomy. In two further studies we have compared th
e analgesic effect of intraperitoneal bupivacaine against wound infiltratio
n with bupivacaine, and against intraperitoneal bupivacaine with the additi
on of a non-steroidal anti-inflammatory drug (NSAID) in patients undergoing
laparoscopic cholecystectomy. Two consecutive studies were performed, In t
he first, patients in group 1 were given 20 ml of 0.25 % bupivacaine into t
he peritoneal cavity; patients in group 2 were given 20 ml of 0.25 % bupiva
caine injected into the trocar wounds, In the second study, patients in gro
up 1 were given 20 ml of 0.25 % bupivacaine into the peritoneal cavity; pat
ients in group 2 were given 20 ml of 0.25 % bupivacaine into the peritoneal
cavity and a diclofenac suppository (100 mg) one hour before surgery. Post
operative pain was assessed with a visual analogue pain scale. There was no
difference in pain scores in the two groups in either study. Intraperitone
al bupivacaine is as effective as wound infiltration. The addition of an NS
AID makes no difference in the reduction of postoperative pain following la
paroscopic cholecystectomy.